Reset your DNA to slow the clock

Neo Life |
December 2019
Press

A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young. However, Robert Green says “epigenetic marks in apparently healthy people can tell them meaningful things about their health status is an overreach.”

Apple is offering free genetic tests to all its Silicon Valley employees

CNBC |
December 2019
Press

“It’s really exciting that to see companies move to preserve health, rather than just treating patients when they’re ill,” said Dr. Robert Green, a medical geneticist at Harvard Medical School and a co-founder of a genetics company called Genome Medical.

23 and baby

Nature |
December 2019
Press

We now have the ability to screen for thousands of genetic diseases in newborns. That may not always be the healthy thing to do.

Addressing barriers to expanding genetic counseling

Modern Health Care |
November 2019
Press

Genetic counselors are becoming a bigger part of the healthcare continuum as population health management seeks to more quickly screen for, assess and prevent illness. Read on as genetic counselors in the field, including our own, Carrie Blout, address some of the barriers in genetic counseling.

China’s genetics giant wants to tailor medicine to your DNA

Bloomberg |
November 2019
Press

BGI is racing toward a world where your DNA informs your medical decisions—and maybe some of your personal ones. Bloomberg asks Dr. Robert Green on his thoughts regarding the medical advances in genomics in China and how they compare to those in the US.

Preventive Genomics Brochure

October 2019
Press

Please view our online brochure if you are interested in learning more about the Preventive Genomics Clinic at Brigham & Women’s Hospital

Frequently Asked Questions

October 2019
Press

Want more information on the Preventive Genomics Clinic? Check out answers to our most frequently asked questions.

Brigham and Women’s Hospital opens preventive genomics clinic

Genome Web |
August 2019
Press

“Preventive genomics is not yet recommended as standard of care,” Robert Green, director of the Preventive Genomics Clinic, said in a statement. “But for over two decades, our NIH-funded, randomized trials in translational genomics have generated consistent evidence that there are more potential medical benefits and fewer risks than previously considered. It is time for … Continued

NHGRI Announces Six Inaugural Genomic Innovator Awards

National Human Genome Research Institute |
August 2019
Press

Dr. Jason Vassey was announced as one of six recipients for the Genomic Innovator supporting early career investigators researching genome biology, genomic medicine, technology development and societal implications of genomic advances.

FDA stepping up actions against PGx testing, forcing some labs to stop reporting drug information

Genome Web |
August 2019
Press

Researchers led by Robert Green at Brigham and Women’s Hospital looked at whether consumers getting direct-to-consumer genetic testing were using PGx tests to change treatment decisions. Although this study relied on self-reported data from participants, it suggests that less than 1 percent could have made unsupervised medication changes based on their genetic test results.

Partners Biobank surpasses 100,000 participants

Brigham Bulletin |
August 2019
Press

“I would have never known that I was at risk if i hadn’t donated to the Biobank,” said Kristine Trudeau who knowingly enrolled in the Partners HealthCare Biobank because she wanted to help advance medicine and potentially save lives. She did not expect that it would save her own.

Should you get a home genetic test?

Harvard health Publishing |
February 2019
Press

More and more people want to explore their own medical data, and a DTC genetic test is one way to begin to understand some aspects of your future health.

The genetic counselor with a $4,000 DNA test

Bloomberg |
July 2019
Press, Video

At a new clinic in Boston, genetic counselor Carrie Blout helps healthy patients get their DNA tested for predispositions to more than 2500 diseases. Bloomberg’s Aki Ito goes through the testing herself, trialing a controversial technology at the forefront of modern medicine.

Should you find out if you’re at risk of Alzheimer’s?

The Wall Street Journal |
July 2019
Press

Dr. Robert Green on learning of your genetic risk to developing Alzheimer’s quotes:  “Not everything has a pill or medical-prevention plan, but many information-seeking persons can find all sorts of benefits in better understanding their risk of future disease.”

The promises and pitfalls of gene sequencing for newborns

NPR |
July 2019
Press

A decade ago, it seemed inevitable that every newborn would get a complete gene scan. But there are technical challenges and practical concerns.Dr. Robert Green, from Brigham and Women’s Hospital in Boston, voiced one view about doing that: “If sequencing reveals health risks at any point in life, and if that’s good, then it’s better … Continued

Blood samples reveal valuable data — and life-changing surprises for donors

The Boston Globe |
July 2019
Press

Kristine Trudeau agreed to donate a sample of blood to the Partners HealthCare Biobank, a resource for researchers across the Partners hospital network — including the Brigham and Massachusetts General. By analyzing large numbers of blood samples, scientists can learn how genes contribute to disease. Trudeau shares her experiences as being one the many participants … Continued

Sanford Health taps Harvard, Brigham and Women’s for genetic screening study

Genome Web |
June 2019
Press

Under the four-year collaboration, experts in genomic medicine from Harvard and Brigham and Women’s will help guide Sanford researchers in using and interpreting data collected through the Sanford Chip, a $49 pharmacogenomic test to identify genetic risk factors for medication use and more accurately prescribe medications.

Don’t count on 23andMe to detect most breast cancer risks, study warns

New York Times |
April 2019
Press

Nearly 90 percent of participants who carried a BRCA mutation would have been missed by 23andMe’s test, geneticists found. Dr Robert Green comments, “I think people have the right to their own genetic information, but with that right comes a responsibility. If you are going to go around the medical mainstream, read the caveats.”

DNA testing could save young lives through early intervention

The Harvard Gazette |
March 2019
Press

Pediatric oncologist Dr. Lisa Diller, the Lillian Gollay Knafel Fellow at the Radcliffe Institute for Advanced Study, is exploring genetic testing in newborns that could help them escape severe health consequences.

Genetically sequencing healthy babies yielded surprising results

Leapsmag |
January 2019
Press

As principal investigator on the BabySeq Project, Dr. Robert Green shares the findings from the project along with discussion on the expectations and benefits of sequencing healthy babies. Green states, “Suddenly the information available in the genome of even an apparently healthy individual is looking more robust, and the prospect of preventive genomics is looking … Continued

Baby sequencing steps

Nature Reviews Genetics |
January 2019
Press

In the BabySeq Study, a total of 88% of sequenced neonates had carrier status for one or more rare genetic variants known to be associated with recessive diseases.

More than 10% of healthy people have monogenic risk variants

RareDR |
December 2018
Press

Robert Green, MD, MPH, the projects’ principal investigator suggests “These results are unexpected and exciting, suggesting that if we examine enough well-established, disease-associated genes, we will unearth monogenic risk variants in more than 10 percent of purportedly healthy individuals.”